BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 17917066)

  • 1. PIP3 pathway in regulatory T cells and autoimmunity.
    Kashiwada M; Lu P; Rothman PB
    Immunol Res; 2007; 39(1-3):194-224. PubMed ID: 17917066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence that SHIP-1 contributes to phosphatidylinositol 3,4,5-trisphosphate metabolism in T lymphocytes and can regulate novel phosphoinositide 3-kinase effectors.
    Freeburn RW; Wright KL; Burgess SJ; Astoul E; Cantrell DA; Ward SG
    J Immunol; 2002 Nov; 169(10):5441-50. PubMed ID: 12421919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphatidylinositol (3,4) bisphosphate-specific phosphatases and effector proteins: A distinct branch of PI3K signaling.
    Li H; Marshall AJ
    Cell Signal; 2015 Sep; 27(9):1789-98. PubMed ID: 26022180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of phosphoinositide 3-kinase signaling in autoimmunity.
    Oak JS; Fruman DA
    Autoimmunity; 2007 Sep; 40(6):433-41. PubMed ID: 17729037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphoinositide lipid phosphatases: natural regulators of phosphoinositide 3-kinase signaling in T lymphocytes.
    Harris SJ; Parry RV; Westwick J; Ward SG
    J Biol Chem; 2008 Feb; 283(5):2465-9. PubMed ID: 18073217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutting edge: T cell requirement for CD28 costimulation is due to negative regulation of TCR signals by PTEN.
    Buckler JL; Walsh PT; Porrett PM; Choi Y; Turka LA
    J Immunol; 2006 Oct; 177(7):4262-6. PubMed ID: 16982858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SHIP regulates the reciprocal development of T regulatory and Th17 cells.
    Locke NR; Patterson SJ; Hamilton MJ; Sly LM; Krystal G; Levings MK
    J Immunol; 2009 Jul; 183(2):975-83. PubMed ID: 19542365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human T-cell leukemia virus type I tax down-regulates the expression of phosphatidylinositol 3,4,5-trisphosphate inositol phosphatases via the NF-kappaB pathway.
    Fukuda RI; Tsuchiya K; Suzuki K; Itoh K; Fujita J; Utsunomiya A; Tsuji T
    J Biol Chem; 2009 Jan; 284(5):2680-2689. PubMed ID: 19047050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemistry and structure of phosphoinositide phosphatases.
    Kim YJ; Jahan N; Bahk YY
    BMB Rep; 2013 Jan; 46(1):1-8. PubMed ID: 23351377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct IL-2 receptor signaling pattern in CD4+CD25+ regulatory T cells.
    Bensinger SJ; Walsh PT; Zhang J; Carroll M; Parsons R; Rathmell JC; Thompson CB; Burchill MA; Farrar MA; Turka LA
    J Immunol; 2004 May; 172(9):5287-96. PubMed ID: 15100267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum withdrawal-induced accumulation of phosphoinositide 3-kinase lipids in differentiating 3T3-L6 myoblasts: distinct roles for Ship2 and PTEN.
    Mandl A; Sarkes D; Carricaburu V; Jung V; Rameh L
    Mol Cell Biol; 2007 Dec; 27(23):8098-112. PubMed ID: 17893321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTEN permits acute increases in D3-phosphoinositide levels following TCR stimulation but inhibits distal signaling events by reducing the basal activity of Akt.
    Seminario MC; Precht P; Bunnell SC; Warren SE; Morris CM; Taub D; Wange RL
    Eur J Immunol; 2004 Nov; 34(11):3165-75. PubMed ID: 15468057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cells transduce T-cell receptor signal strength by generating different phosphatidylinositols.
    Hawse WF; Cattley RT
    J Biol Chem; 2019 Mar; 294(13):4793-4805. PubMed ID: 30692200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TCR Signaling and CD28/CTLA-4 Signaling Cooperatively Modulate T Regulatory Cell Homeostasis.
    Holt MP; Punkosdy GA; Glass DD; Shevach EM
    J Immunol; 2017 Feb; 198(4):1503-1511. PubMed ID: 28053234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. INPP4B and PTEN Loss Leads to PI-3,4-P2 Accumulation and Inhibition of PI3K in TNBC.
    Reed DE; Shokat KM
    Mol Cancer Res; 2017 Jun; 15(6):765-775. PubMed ID: 28196852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compound heterozygosity for Pten and SHIP augments T-dependent humoral immune responses and cytokine production by CD(4+) T cells.
    Moody JL; Jirik FR
    Immunology; 2004 Jul; 112(3):404-12. PubMed ID: 15196208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leading-edge research: PtdIns(3,4,5)P3 and directed migration.
    Franca-Koh J; Kamimura Y; Devreotes PN
    Nat Cell Biol; 2007 Jan; 9(1):15-7. PubMed ID: 17199126
    [No Abstract]   [Full Text] [Related]  

  • 18. Requirement of phosphatidylinositol(3,4,5)trisphosphate in phosphatidylinositol 3-kinase-induced oncogenic transformation.
    Denley A; Gymnopoulos M; Kang S; Mitchell C; Vogt PK
    Mol Cancer Res; 2009 Jul; 7(7):1132-8. PubMed ID: 19584261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTEN, but not SHIP2, suppresses insulin signaling through the phosphatidylinositol 3-kinase/Akt pathway in 3T3-L1 adipocytes.
    Tang X; Powelka AM; Soriano NA; Czech MP; Guilherme A
    J Biol Chem; 2005 Jun; 280(23):22523-9. PubMed ID: 15824124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphoid susceptibility to the Aggregatibacter actinomycetemcomitans cytolethal distending toxin is dependent upon baseline levels of the signaling lipid, phosphatidylinositol-3,4,5-triphosphate.
    Shenker BJ; Walker LP; Zekavat A; Boesze-Battaglia K
    Mol Oral Microbiol; 2016 Feb; 31(1):33-42. PubMed ID: 26299277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.